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shRNAQuantitative validation of gene regulatory networks (GRNs) inferred from observational expression data is a dif-
ﬁcult task usually involving time intensive and costly laboratory experiments. We were able to show that gene
knock-down experiments can be used to quantitatively assess the quality of large-scale GRNs via a purely
data-driven approach (Olsen et al. 2014). Our new validation framework also enables the statistical comparison
of multiple network inference techniques, which was a long-standing challenge in the ﬁeld.
In this Data in Brief we detail the contents and quality controls for the gene expression data (available fromNCBI
Gene Expression Omnibus repository with accession number GSE53091) associated with our study published in
Genomics (Olsen et al. 2014). We also provide R code to access the data and reproduce the analysis presented in
this article.
© 2015 Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/)./colorectal tumor tissue
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Short hairpin RNA experiments
We selected eight genes known to be involved in the RAS pathway,
namely CDK5, HRAS, MAPK1, MAPK3, MAP2K1, MAP2K2, NGFR and
RAF1. They are hereafter referred to as ‘core genes’ due to their rele-
vance in the RAS pathway [2] and their consequential importance in co-
lorectal cancer [8].
The knock-down experiments were performed on the eight core
genes using short hairpin RNA (shRNA) in two colorectal cancer cell
lines SW480 and SW620 [4]. For each knock-down there are six repli-
cates (except CDK5 in SW620 with ﬁve replicates) with three different
ing 125 samples. We used the Affymetrix GeneChip HG-U133PLUS2
platform to proﬁle the gene expression of each sample.Quality control
We used the simpleaffy Bioconductor package [7] to check the qual-
ity of each individual CEL ﬁle. Fig. 1 shows that a majority of ﬁles con-
tains a sufﬁciently large percentage of present calls (N40%, except for
biological replicates one and two and HRAS biological replicate three
with 39.58%) and all scale factors lie within a 3-fold range which com-
plies with the good quality guidelines from Affymetrix [1]. In more-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
124 C. Olsen et al. / Genomics Data 4 (2015) 123–126detail, we can observe that those CEL ﬁles that were generated in the
early stages of the data generation are of lower quality than the rest of
the ﬁles, namely the biological replicates one and two (Fig. 2 and
Table 1).
Normalization
The raw and normalized data are available from NCBI Gene Expres-
sion Omnibus repository [3] with accession number GSE53091.
Basic analysis
A successful knock-down experiment should result in signiﬁcantly
lower expression compared to the unperturbed samples. Here, we as-
sess the quality of a knock-down experiments by testing the difference
between matched knock-down samples versus nontarget control sam-
ples using a Wilcoxon signed rank test [6].
In Fig. 3, we show the difference between knock-down and control
sample expression for each of the eight knock-downs for both cell-
lines together. In each plot, the knocked-down gene is highlighted in
blue and the obtained p-values are represented by symbols in the bot-
tom of each plot. The signiﬁcance levels are represented as follows:
‘***’ for p b 0.001, ‘**’ for p b 0.01, ‘*’ for p b 0.05 and ‘-’ for p b 0.1.
From the eight plots in Fig. 3, we can observe that the difference in
expression between knock-down and control samples is signiﬁcant for
all of the eight knock-downs (the differential expression of the blue
boxes is signiﬁcantly lower than zero). In our study [5], we determined
the set of signiﬁcantly affected genes for each of the eight knock-downs.
For example, the knock-down of RAF1 signiﬁcantly changes the expres-
sion of MAP2K2 and NGFR with p-values b 0.001 (only considering the
eight core genes).We then used the set of signiﬁcantly affected genes to
quantitatively validate inferred gene regulatory interactions.
Discussion
In this article we described a unique data set containing RAS
pathway-related gene knock-down experiments in two different colon
cancer cell-lines. It contains the expression values from the knock-
down of eight genes as well as three different controls in six biological
replicates. The genome-wide gene expression was measured using the
Human Genome U133 Plus 2.0 Array. This data was recently used in a
published study on the validation of regulatory gene networks [5].
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Appendix A. Supplementary data
Supplementary data to this article can be found online at http://dx.
doi.org/10.1016/j.gdata.2015.03.011.Fig. 1. Quality controls for the Affymetrix Raw data generated in [5]. CEL ﬁle names for
each experiment is provided on the left side, followedby thepercentage of present and ab-
sent calls (in red) following the Affymetrix guidelines. The blue region in themiddle of the
plot represents the 3-fold region for scale factor as this region is considered as acceptable
according to Affymetrix guidelines; any scale factor outside this region is drawn in red as it
is considered an indicator of poor quality. Beta-actin and GAPDH 3′–5′ ratios are also rep-
resented on the right side by triangles and circles, respectively; ratio higher than 1.25 are
drawn in red as they are considered indicators of poor quality.
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Fig. 2. Call percentage for each CEL ﬁle. The colors correspond to the biological replicate number. The quality of the ﬁrst two replicates is lower than for the remaining ﬁve replicates.
Table 1
For each biological replicate, the time of data generation is speciﬁed. There are three main batches: 2008 (biological replicates 1), 2009 (biological replicates 2) and 2011 (biological
replicates 3–7).
Date
2008-12-16 2008-12-17 2009-07-15 2011-07-19 2011-07-20
Biological replicate 1 11 10 0 0 0
2 0 0 22 0 0
3 0 0 0 15 5
4 0 0 0 19 1
5 0 0 0 17 3
6 0 0 0 18 2
7 0 0 0 2 0
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Fig. 3. Each plot shows the difference of expression for the eight core genes. The knocked down gene highlighted in light blue. The signiﬁcance level is indicated by ‘-’ for p b 0.1, ‘*’ for
p b 0.05, ‘**’ for p b 0.01 and ‘***’ for p b 0.001 using a Wilcoxon signed rank test.
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